• Phare
  • Validé par KD/KO

Anticorps Recombinant de lapin anti-NAT10

NAT10 Recombinant Antibody for WB, IF/ICC, IP, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, IF/ICC, IP, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

5B9

N° de cat : 82585-1-PBS

Synonymes

N acetyltransferase 10, KIAA1709, EC:2.3.1.-, ALP, 5B9



Informations sur le produit

82585-1-PBS cible NAT10 dans les applications de WB, IF/ICC, IP, Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène NAT10 Protéine recombinante Ag4184
Nom complet N-acetyltransferase 10 (GCN5-related)
Masse moléculaire calculée 1025 aa, 116 kDa
Poids moléculaire observé 116 kDa
Numéro d’acquisition GenBankBC035558
Symbole du gène NAT10
Identification du gène (NCBI) 55226
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

NAT10 (N-acetyltransferase 10) is a nucleolar protein that is involved in regulation of telomerase activity, DNA damage response, and cytokinesis. It also plays a role in maintaining nuclear shape. Inhibition of NAT10 has been reported to rescue the misshapen nuclei in laminopathic cells via microtubule reorganization. The specificity of this antibody has been tested by siRNA (PMID: 24786082). NAT10 regulates mitotic cell fate by acetylating Eg5. NAT10 depletion results in multinuclear giant cells, which is the hallmark of mitotic catastrophe (PMID: 35210604). NAT10 plays a crucial role in carcinogenesis through influencing EMT, hypoxia, ribosomal biogenesis and overall, promoting translational efficiency. Recently, we reported that treating cancer cells with Remodelin, a small molecule inhibitor of NAT10, causes alteration in global lipid metabolism (PMID: 36149760).

{{ptg:RelatedPrimaryAntibodies}}